News | December 10, 2008

China Orders 200 B-CAD Systems from Medipattern

December 10, 2008 – The Medipattern Corp. said the China Primary Health Care Foundation (CPHCF) has purchased 200 B-CAD systems as part of a pilot breast-screening program for rural China.

The CPHCF is purchasing equipment for rural hospitals, including B-CAD, as part of their large-scale trial to finalize breast-screening protocol prior to launching their national screening program. Delivery and installation of the first 50 B-CAD software systems will occur during the first quarter of 2009, with subsequent scheduled deliveries in 36 unit increments throughout the first half of 2009. Medipattern will receive a portion of the value of the contract in the form of a down payment, followed by further payments totaling 90 percent of the value of the shipments upon receipt of the software in China. Additional financial and operational details of the transaction were not disclosed due to competitive reasons.

“Breast density has been a limiting factor in being able to perform screening in the People’s Republic of China. Recent studies show that breast ultrasound imaging is more effective on dense breast types than screening mammography and that B-CAD improves diagnostic accuracy of breast ultrasound imaging. It is a necessary part of every breast ultrasound exam and as such we include it with every ultrasound unit that we order for breast diagnosis and screening,” said Tang Jie, M.D., director of ultrasound for the PLA 301 in Beijing. “Breast ultrasound is a central part of our screening program in China.”

Breast cancer is a significant issue in China. The incidence of breast cancer has increased by at least 27 percent over the past decade, and 40 percent of the Chinese women diagnosed with breast cancer die within five years because the cancer is already very advanced when it is diagnosed. According to the October 27, 2008 issue of the Shanghai Daily, Shanghai has the highest incidence of breast cancer in China. More than 60 in every 100,000 women in the city contract the disease, which is three times higher than the incidence in the U.S. and Canada.

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Videos | Artificial Intelligence | December 19, 2017
A post-game roundup by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell on the key trend of artifici
iCAD's PowerLook Tomo Detection Experiences Growing Adoption
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Infervision Launches AI Platform to Help Radiologists Diagnose Stroke Faster
Technology | Computed Tomography (CT) | November 28, 2017
Infervision is introducing what it calls the first and only artificial intelligence (AI) platform to help radiologists...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Zebra Medical Vision Collaborating With Google Cloud on AI-Based Imaging Platform
News | Artificial Intelligence | November 09, 2017
Deep learning imaging analytics company Zebra Medical Vision announced that all its current and future radiology...
CureMetrix Expands Medical Advisory Board
News | Computer-Aided Detection Software | November 08, 2017
November 8, 2017 — CureMetrix, a company developing...
PowerLook Tomo Detection Named 2017 New Hampshire High Technology Council Product of the Year
News | Computer-Aided Detection Software | October 27, 2017
iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High...
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
20/20 GeneSystems Launches AI-Based Lung Cancer Detection Technology in China
Technology | Lung Cancer | August 28, 2017
20/20 GeneSystems Inc. recently released in China what is believed to be the world’s first machine learning algorithm...
Overlay Init